Exagen_Full_CMYK_Print_NoTagline 3.15.24.png
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
September 04, 2024 16:05 ET | Exagen Inc.
CARLSBAD, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2024 Cantor Global...
Elevar Logo for Common Use.png
Elevar Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference
September 21, 2023 09:00 ET | Elevar Therapeutics
FORT LEE, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...
Nouveau Logo communiqué de presse.JPG
Theratechnologies fera une présentation à la conférence Cantor Fitzgerald Global Healthcare 2023
September 20, 2023 07:00 ET | Theratechnologies
MONTRÉAL, 20 sept. 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique axée sur la mise au point...
Nouveau Logo communiqué de presse.JPG
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
September 20, 2023 07:00 ET | Theratechnologies
MONTREAL, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
exagen-logo-440x386-1.jpg
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 12, 2023 16:05 ET | Exagen Inc.
SAN DIEGO, California, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Cantor...
CISO_Logo_ Press_Release update (1).jpg
Cerberus Sentinel Announces Proposed Public Offering of Common Stock
February 13, 2023 16:01 ET | Cerberus Sentinel
Scottsdale, Ariz., Feb. 13, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Cerberus Cyber Sentinel Corporation (“Cerberus Sentinel” or the “Company”) (NASDAQ: CISO), an industry leader as a managed...
exagen-logo-440x386-1.jpg
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
November 08, 2022 16:05 ET | Exagen Inc.
SAN DIEGO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following fourth...
logo.jpg
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
September 16, 2021 08:30 ET | Processa Pharmaceuticals, Inc.
HANOVER, MD, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to...
AptinyxLogo_FullColor_RGB.jpg
Aptinyx to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
September 30, 2019 07:03 ET | Aptinyx Inc.
EVANSTON, Ill., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and...
Logo_Biofrontera_AG.png
Biofrontera to Present at the Cantor Fitzgerald Global Healthcare Conference
September 24, 2018 07:44 ET | Biofrontera AG
Leverkusen, Germany, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today announced that Thomas...